Non‐invasive detection of hippocampal sclerosis: correlation between metabolite alterations detected by 1H‐MRS and neuropathology

Authors:

Abstract
We assessed 1H‐MRS as a screening tool for detection of hippocampal sclerosis in patients with temporal lobe epilepsy (TLE). 1H‐MRS was carried out in the hippocampus of 23 patients with unilateral TLE. Metabolite alterations detected by 1H‐MRS correlated with degree of segmental neuronal cell loss and amount of astrogliosis. Positive correlation was found between total N‐Acetylaspartate (tNAA) reduction and neuronal density in hippocampal CA1 (P < 0.001), CA3 (P = 0.015), and CA4 subfields (P = 0.031) and the dentate gyrus (P = 0.006). Neuronal cell loss in CA1 turned out to be the most predictive and only significant variable for tNAA reduction (P = 0.027). The association between myo‐inositol (m‐Ins) and astroglial glial fibrillary acidic protein (GFAP) expression revealed significantly increased m‐Ins concentrations associated with diffuse astrogliosis (m‐Ins = 6.4 ± 1.1 institutional units) compared with gliosis restricted to isolated sectors of the hippocampus (i.e. hilus) (m‐Ins = 5.2 ± 1.2 institutional units) (P = 0.039). A negative correlation was found between m‐Ins and neuronal loss in the CA4 subfield of the hippocampus (P = 0.028). Our results support 1H‐MRS as a suitable non‐invasive method for preoperative identification of hippocampal sclerosis in patients with TLE. The extent of tNAA reduction correlates with hippocampal neuronal cell density. Furthermore, m‐Ins is associated with the extent of hippocampal astrogliosis. Copyright © 2007 John Wiley & Sons, Ltd.

This publication has 35 references indexed in Scilit: